Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

FDA approves Astra Zeneca’s TRUQAP (ca

AstraZeneca’s TRUQAP (New Molecule Capivasertib) in combination with Faslodex (Fulvestrant) has been approved in the

Ascendis Pharma announces European appro

Danish Pharma firm Ascendis Pharma announced the European Commission approval for palopegteriparatide (Yorvipath), for treatment

FDA approves BMS’ Repotrectinib (Augty

Bristol Myers Squibb Augtyroâ„¢ (repotrectinib) is approved for treatment of adult patients with ROS1-positive non-small

USFDA approves Santhera’s New Molecula

Vamorolone is a synthetic corticosteroid approved by USFDA for the treatment of Duchenne Muscular Dystrophy

FDA approves NCE Gepirone (EXXUA) for Ma

Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company announced approval of Exxuaâ„¢ (gepirone hydrochloride extended-release tablets)

FDA on Friday approved Lexicon’s heart

</a> Marketing Authorisation on the request of MA holder Guidehouse Germany GmbH)